Prevalence of Musculoskeletal Disorders

November 28, 2024 updated by: Osama Abdelaziz, Cairo University

Prevalence of Musculoskeletal Disorders Among Egyptian Students in the Faculty of Applied Arts

This observational cross-sectional study aims to determine the prevalence of musculoskeletal disorders (MSDs) among Egyptian students in the Faculty of Applied Arts. Using the Arabic version of the extended Nordic Musculoskeletal Questionnaire (NMQ-E), the study will assess the prevalence, distribution, and associated factors of musculoskeletal symptoms over the last 12 months and 7 days. A sample of 250 participants, aged 20-22 years and of both genders, will be recruited. Exclusion criteria include obesity, pregnancy, history of neuropathy, unstable medical conditions, or trauma-related musculoskeletal problems. The results will provide insights into MSD prevalence and help guide interventions for this population.

Study Overview

Detailed Description

Study Title: Prevalence of Musculoskeletal Disorders Among Egyptian Students in the Faculty of Applied Arts

Study Design:

This is an observational, cross-sectional study aimed at investigating the prevalence of musculoskeletal disorders (MSDs) and associated risk factors among Egyptian students enrolled in the Faculty of Applied Arts during their last three academic years. The study will collect demographic data (age, gender) and assess musculoskeletal symptoms using the Nordic Musculoskeletal Questionnaire (NMQ-E).

Study Population:

The target population includes approximately 9,600 students from the Faculty of Applied Arts in Egypt. A sample of 250 participants will be recruited based on eligibility criteria.

Inclusion Criteria:

Egyptian students from the Faculty of Applied Arts. Age range: 20-22 years. Both genders included.

Exclusion Criteria:

Obesity. Pregnancy. History of neuropathy or other neurological disorders such as lumbar plexopathy, spinal stenosis, and nerve root compression.

Unstable medical conditions. History of central nervous system malignancy (primary or metastatic). Musculoskeletal problems due to trauma or previous surgery.

Sample Size Calculation:

The sample size was determined using a sample size calculator with a confidence interval of 95% and α level of 0.05. From a population of 9,600, a minimum of 250 participants was required to achieve statistical power.

Instrumentations:

The Arabic version of the extended Nordic Musculoskeletal Questionnaire (NMQ-E) will be utilized. The NMQ is a validated tool for assessing musculoskeletal symptoms, including pain prevalence and anatomical distribution.

Key Sections of NMQ-E:

Section 1: 40 forced-choice items identifying musculoskeletal problem areas, supported by a body map. Symptoms over the last 12 months and the past 7 days will be evaluated.

Section 2: Additional questions on neck, shoulders, and lower back, covering symptom duration, functional impact, professional assessments, and recent musculoskeletal problems.

Procedure:

Participants will be recruited from the Faculty of Applied Arts and asked to complete the NMQ-E online or in person. Data on musculoskeletal symptoms and ergonomic practices will be collected over a specific timeframe.

Validity and Reliability of NMQ-E:

Validity:

Content validity is supported by expert review and alignment with established measures of musculoskeletal health.

Criterion validity demonstrated strong correlations between NMQ responses and clinical assessments (sensitivity: 66-92%; specificity: 71-88%).

Reliability:

High test-retest reliability observed in various populations. Internal consistency confirmed via Cronbach's alpha.

Data Analysis and Statistical Design:

The collected data will be analyzed using statistical software, employing:

Descriptive statistics (mean, standard deviation, percentages). Statistical significance set at p < 0.05.

Study Type

Observational

Enrollment (Estimated)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Osama Abdelaziz physiotherapist, Master Degree
  • Phone Number: +20 102 530 6119
  • Email: Osamasalih143@gmail.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

students enrolled in the Faculty of Applied Art at a university in Egypt

Description

Inclusion Criteria:

  1. 250 Egyptian students from different Faculties of Applied Art.
  2. Age (20-22) years old
  3. both genders will be included.

Exclusion Criteria:

  1. Obesity.
  2. Pregnancy.
  3. Patients who had history of any other neuropathy.
  4. Unstable medical condition.
  5. Other neurological disorders causing pain as lumbar plexopathy, spinal stenosis, and spinal nerve root compression.
  6. History of central nervous system primary or metastatic malignancy
  7. student having any musculoskeletal problems due to other causes as accidents or a previous operation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
musculoskeletal symptoms
Time Frame: one month
information on musculoskeletal symptoms experienced by participants,
one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 5, 2025

Primary Completion (Estimated)

April 1, 2025

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

November 26, 2024

First Submitted That Met QC Criteria

November 26, 2024

First Posted (Actual)

November 29, 2024

Study Record Updates

Last Update Posted (Actual)

December 3, 2024

Last Update Submitted That Met QC Criteria

November 28, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/005019

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Disorders

Clinical Trials on Arabic version of The Nordic Musculoskeletal Questionnaire (NMQ) is a standardized questionnaire used to assess musculoskeletal symptoms and disorders in the workplace

Subscribe